Paroxysmal Dystonia and Psychotic Exacerbations in chronic psychosis - Diagnostic dilemmas and preliminary treatment approaches.
Biswa Ranjan MishraTathagata BiswasV S SreerajSantanu NathDebadatta MohapatraRituparna MaitiPublished in: British journal of clinical pharmacology (2023)
Patients with chronic psychosis on prolonged antipsychotic therapy may present with paroxysmal dystonia along with an exacerbation of their psychotic symptoms - Paroxysmal Dystonia and Psychotic Exacerbations (PDPE). The inter-individual variability in the clinical presentations of PDPE can pose challenges in its diagnosis and treatment. The objectives of this work are to a) discuss this rare phenomenon through a series of ten patients and a relevant literature review, b) conceptualise its neurobiological underpinnings, and c) explore the preliminary treatment approaches for its management. Acute stress and/or a dysfunctional GABAergic or dopaminergic system may be implicated in the pathogenesis of PDPE. The episodes respond acutely to parenteral benzodiazepines, while long-term management can be achieved by reducing antipsychotic doses, switching to clozapine or using central GABA-enhancers. This article is the first attempt at conceptualising and exploring treatment options for the rare condition, PDPE and intends to guide future research in this regard.
Keyphrases
- chronic obstructive pulmonary disease
- atrial fibrillation
- deep brain stimulation
- bipolar disorder
- early onset
- end stage renal disease
- cystic fibrosis
- newly diagnosed
- chronic kidney disease
- catheter ablation
- respiratory failure
- patient reported outcomes
- physical activity
- peritoneal dialysis
- intensive care unit
- combination therapy
- case report
- hepatitis b virus
- prognostic factors
- mesenchymal stem cells
- stress induced
- cell therapy
- aortic dissection
- bone marrow
- replacement therapy